Megan Doyle

ORCID: 0000-0003-0024-8922
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Management of metastatic bone disease
  • Brain Metastases and Treatment
  • Spine and Intervertebral Disc Pathology
  • Allergic Rhinitis and Sensitization
  • Dermatology and Skin Diseases
  • Glioma Diagnosis and Treatment
  • Ophthalmology and Visual Impairment Studies
  • Contact Dermatitis and Allergies
  • Spinal Fractures and Fixation Techniques
  • Antioxidant Activity and Oxidative Stress
  • Spondyloarthritis Studies and Treatments
  • Autoimmune and Inflammatory Disorders Research
  • Intraocular Surgery and Lenses
  • Rheumatoid Arthritis Research and Therapies
  • Anesthesia and Neurotoxicity Research
  • Cancer Diagnosis and Treatment
  • Retinopathy of Prematurity Studies
  • Nerve Injury and Rehabilitation
  • Anesthesia and Pain Management
  • Corneal surgery and disorders

Technological University Dublin
2023-2024

University of Nottingham
2024

Janssen (United States)
2013

University of Waterloo
2008

Sunnybrook Health Science Centre
2006-2007

Kentuckiana Pulmonary Associates
2005

Background: The primary objective of this study was to assess whether there an improvement in quality life for patients with brain metastases as measured 1 and 2 months after a course whole-brain radiotherapy. secondary the level agreement between patient proxy scores. Methods materials: Sixty their completed Functional Assessment Cancer Therapy-Brain (FACT-BR) questionnaire independently. Proxies were given instructions answer from patient's perspective. Quality-of-life assessments...

10.1089/jpm.2006.0202 article EN Journal of Palliative Medicine 2007-04-01

1547 Background: Prior studies demonstrated the effectiveness of both BCNU wafer (Gliadel) and TMZ (Temodar) as adjunctive therapies to resection radiation therapy (RT) in pts with initial high grade MG. (Westphal et al. Neuro-Onco 2003; Stupp JCO 2002) This study assessed safety efficacy combination. Methods: is a phase II, multicenter, trial. Eligible were 18–72 years (yrs) age surgically operable, Enrollment began July 2003 continues. After insertion, received concomitant treatment daily...

10.1200/jco.2005.23.16_suppl.1547 article EN Journal of Clinical Oncology 2005-06-01

AimsSince 1999, randomised clinical trials and meta-analyses have reported equal efficacy of pain relief from single- multiple-fraction radiotherapy for bone metastases. A number factors, including limited resources, waiting times, patient convenience, suggest single fraction to be the treatment choice patients. However, international patterns practice indicate that multiple fractions are still commonly used. This study examined whether dose-fractionation schemes used metastases at Rapid...

10.1016/j.clon.2008.01.002 article EN other-oa Clinical Oncology 2008-02-15

This study compared the efficacy of cyclopentolate hydrochloride at 10-, 20- and 30-min post-instillation in White 6- to 7-year-olds, with without prior instillation proxymetacaine hydrochloride. The primary aim was determine if accurate autorefraction values can be obtained sooner than current standard post-cycloplegia. secondary investigate whether enhances efficiency cyclopentolate.

10.1111/opo.13421 article EN cc-by-nc Ophthalmic and Physiological Optics 2024-11-13

Reducing the time between drop instillation and refraction reduces paediatric patients young adults spend in practice, facilitating more eye examinations daily.The current procedure for cycloplegic is to wait at least 30-minutes post-instillation of a before measuring spherical equivalent refraction. This study compared cycloplegia 20- following 0.5% proxymetacaine 1.0% cyclopentolate 12-13-year-olds.Participants were 99 white 12-13-year-olds. One hydrochloride (Minims, w/v, Bausch & Lomb,...

10.1080/08164622.2023.2166398 article EN cc-by-nc-nd Clinical and Experimental Optometry 2023-02-07

10.1016/j.ijrobp.2006.07.982 article International Journal of Radiation Oncology*Biology*Physics 2006-10-15

10.1016/j.ijrobp.2006.07.1005 article EN International Journal of Radiation Oncology*Biology*Physics 2006-10-15
Coming Soon ...